Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer. Phase II study of the Southern Italy Oncology Group (GOIM)

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 22, Issue 3, 1999, Pages 262-266

  Colucci, Giuseppe ^a   Giuliani, Francesco ^a   Gebbia, Vittorio ^b   Testa, Antonio ^b   Borsellino, Nicola ^b   Lelli, Giorgio ^c   Fortunato, Santo ^d   Lopez, Massimo ^e   Maiello, Evaristo ^a   Gebbia, Nicola ^b  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d Analysis Center   (Italy)

^e REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Epidoxorubicin; Etoposide; Gastric cancer

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GASTRECTOMY; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; STOMACH CANCER; TREATMENT OUTCOME; TUMOR BIOPSY;

EID: 0033508650     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199906000-00010     Document Type: Article

References (25)

1. MacDonald JS, Schein PS, Wolley PV. Fluorouracil, mitomycin C and adriamycin (FAM): a new combination chemotherapy for advanced gastric carcinoma. Ann Intern Med 1980;93:533-6.
2. Wilke H, Preusser P, Achterrah N, Schmoll HJ, Fink U, Poliwoda H. Polychemotherapy of gastric carcinoma. In: Hotz J, Mayer HJ, Schmoll HJ, eds. Gastric carcinoma. New York, Springer, 1989: 107-27.
3. Alexander HR, Kelsen DP, Tepper JE. Cancer of the stomach. In: De Vita V, Jr. Hellman S, Rosemberg SA, eds. Cancer, principles and practice of oncology. 4th ed. Philadelphia: JB Lippincott, 1993:818-48.
4. Machover D, Goldschmidt E, Chollat P, et al. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. NCI Monogr 1987;5:193-8.
5. Arbuck SG, Douglass HO, Trave F, Rustum YM. A phase II trial of 5-fluorouracil and high-dose leucovorin in gastric carcinoma and a phase I trial of intraperitoneal 5-fluorouracil and leucovorin. NCI Monogr 1987;5:203-5.
6. Rubin J, Gallager J, Schutt A. Phase II trial of 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric or pancreatic carcinomas [abstract]. Proc Am Soc Clin Oncol 1992; 11:496.
7. Beremberg JL, Tangen C, MacDonald JS, et al. Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. A Southwest Oncology Group Study. Cancer 1995;76:715-9.
8. Colucci G, Giotta F, Maiello E, et al. Efficacy of the association of folinic acid and 5-fluorouracil alone versus folinic acid and 5-fluorouracil plus 4-epidoxorubicin in the treatment of advanced gastric carcinoma. Am J Clin Oncol 1995;18:519-24.
9. Kolaric K, Potrebica V, Stanovnik M. Controlled phase III clinical study of 4-epidoxorubicin + 5-fluorouracil versus 5-fluorouracil alone in metastatic gastric and rectosigmoid cancer. Oncology 1986;43:73-7.
10. Kornek G. Schulz F, De Pich D, et al. A phase I-II study of epirubicin, 5 fluorouracil and leucovorin in advanced adenocarcinoma of the stomach. Cancer 1993;71:2177-80.
11. Neri B, Gemelli MT, Pantalone D, et al. Epirubicin and high dose leucovorin plus 5-fluorouracil in advanced gastric cancer: a phase II study. Anticancer Drugs 1993;4:323-6.
12. Wilke H, Preusser P, Fink U, et al. High dose folinic acid, etoposide and 5-fluorouracil in advanced gastric cancer. A phase II study in elderly patients or patients with cardiac risk. Invest New Drugs 1990;8:65-70.
13. Miller AB, Hoogstraten B, Staquet K, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
14. Klein HO. Long term results with FAMTX (5-fluorouracil, adriamycin, methotrexate) in advanced gastric cancer. Cancer Res 1989;9:1025-6.
15. Wils JA, Klein HO, Wagener DJT, et al. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin-a step ahead in the treatment of advanced gastric cancer. A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group. J Clin Oncol 1991;9: 827-31.
16. Cocconi G. Chemotherapy of advanced gastric carcinoma: to be completely rewritten? Ann Oncol 1994;5:8-11.
17. Preusser P, Wilke H, Achterrah N, et al. Phase II study with the combination etoposide, doxorubicin and cisplatin. J Clin Oncol 1989;7:1310-7.
18. O'Connell MJ. Etoposide, doxorubicin and cisplatin chemotherapy for advanced gastric cancer: an old lesson revisited. J Clin Oncol 1992;10:515-6.
19. Wils J. The treatment of advanced gastric cancer. Semin Oncol 1996;23:397-406.
20. Kelsen D, Atiq O, Saltz L, et al. FAMTX versus etoposide, doxorubicin and cisplatin in gastric cancer. A random assignment trial in gastric cancer. J Clin Oncol 1992;10:541-8.
21. Di Lauro L, Capomella E, Vici P, et al. Cisplatin, epirubicin and fluorouracil (PEF) for advanced measurable gastric carcinoma [abstract]. Proc Am Soc Clin Oncol 1995;14:503.
22. Osswaldt IL, Kunz W. Therapeutic synergism of etoposide and 5-fluorouracil combined sequentially in advanced leukemia. J Cancer Res Clin Oncol 1987;113:53-7.
23. Di Bartolomeo M, Bajetta E, de Braud F, et al. Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy. Oncology 1995;52:41-4.
24. Taal BG, Teller FGM, ten Bokkel Huiniuk WW, Boot H, Beijnen JH, Dubbelman R. Etoposide, leucovorin, 5-fluorouracil (ELF) combination chemotherapy for advanced gastric cancer: experience with two treatment schedules incorporating intravenous or oral etoposide. Ann Oncol 1994;5:90-2.
25. Niemeier E, Clemm CH, Weber B, Unterburger P. Results of ELF regimen in the treatment of advanced gastric cancer In: Siewert JR, Roder JD, eds. Progress in gastric cancer research. Bologna: Monduzzi, 1997:1541-4.